Pharmaceutical Care
Management Association
325 7th Street, NW
Washington, DC 20004
Main: 202.756.5700
©2022 PCMA. All Rights Reserved.
A data-driven look at the Medicare Part B and Part D drugs that might qualify for the “small biotech” exemption from drug price negotiation in the Inflation Reduction Act.
In just two years, six new pharmacy benefit companies entered the marketplace, an almost nine percent increase. Today there are 73 full-service PBMs in operation. This demonstrates that the marketplace is not only diverse but becoming more competitive over time.
Given all the recent attention around pharmacy benefit companies and prescription drug costs, I thought it would be helpful to create a primer of what exactly a pharmacy benefit company is and does.
PCMA Vice President, Policy, Angela Banks talks with health policy expert Alex Brill about competition in the prescription drug marketplace and why this is the best way to reduce prescription drug costs. They discuss recent
November is National Diabetes Month. In this conversation, hosted by PCMA’s Angela Banks, we discuss the work that PBMs are currently doing to help millions of patients with diabetes manage their care. Express Scripts’ Chief
Our focus is on prescription drug rebates. How do they work? Why do they work? How do they benefit consumers? And why are they currently under attack by some policymakers and drug manufacturers? The guest
Check out some of the latest news within the PBM industry below.
Senior Vice President,
Strategic Communications
kpayne@pcmanet.org
Assistant Vice President,
Strategic Communications
glopes@pcmanet.org
202-756-5713
Director,
Strategic Communications
mbaldyga@pcmanet.org
202-756-5714
Pharmacy Benefit Managers (PBMs) are your advocates in the health care system, working to lower prescription drug costs for patients and payers across the country.
PBMs are working to help 266 million patients get the prescriptions they need during the pandemic.
Better access. Better Cost. Better Health.
PCMA’s SmartBrief is a daily collection of news highlights for the pharmaceutical industry. Below are a few from today.
©2022 PCMA. All Rights Reserved.